Thermo Fisher Scientific Inc. (NYSE:TMO) is listed among the 14 Best Pharma Dividend Stocks to Buy in 2025. Despite a 21% stock decrease in 2025, the company remains strong with diverse operations and high-margin revenue streams. In Q1 2025, it reported $10.36 billion in revenue, beating estimates by $130 million.

Thermo Fisher Scientific Inc. (NYSE:TMO) is a reliable dividend payer, with an operating cash flow of $723 million and free cash flow of $373 million in the latest quarter. The company raised its dividend for the eighth consecutive year, offering a quarterly dividend of $0.43 per share and a yield of 0.42% as of July 17.

While TMO shows investment potential, some AI stocks may offer greater upside with lower risk. Explore our free report on the best short-term AI stock for potential benefits from Trump-era tariffs and onshoring trends. Thermo Fisher Scientific Inc. presents a solid investment opportunity, but other AI stocks may offer better upside potential.

Read more at Yahoo Finance: Steady Payouts in a Growing Market